Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $17.08B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.20B | 7.0% |
| Business Acquisitions | $195.0M | 1.1% |
| Other Investing | $4.26B | 24.9% |
| Stock Repurchases | $2.80B | 16.4% |
| Other Financing | $2.90B | 17.0% |
| Other | $4.57B | 26.8% |
| Net Cash Flow | $1.16B | 6.8% |